Enzo Biochem
ENZ
$1.05
Share price
-1.87%
Change (1 day)
-57.49%
Change (1 year)
Categories
Revenue for Enzo Biochem (ENZ)
Revenue in 2024 (TTM): $12.8 M
According to Enzo Biochem's latest financial reports the company's current revenue (TTM) is $12.8 M. In 2023 the company made a revenue of $11.76 M a decrease over the years 2022 revenue that were of $87.65 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Enzo Biochem from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | $12.8 M | 8.83% |
| 2023 | $11.76 M | -86.58% |
| 2022 | $87.65 M | -24.17% |
| 2021 | $0.11 B | 36.85% |
| 2020 | $84.46 M | 5.43% |
| 2019 | $80.11 M | -17.49% |
| 2018 | $97.09 M | -10.42% |
| 2017 | $0.10 B | 4.35% |
| 2016 | $0.10 B | 6.05% |
| 2015 | $97.95 M | 1.36% |
| 2014 | $96.63 M | 4.8% |
| 2013 | $92.21 M | -10.44% |
| 2012 | $0.10 B | 0.81% |
| 2011 | $0.10 B | 4.67% |
| 2010 | $97.57 M | 4.16% |
| 2009 | $93.67 M | 17.95% |
| 2008 | $79.41 M | 28.27% |
| 2007 | $61.91 M | 54.38% |
| 2006 | $40.1 M | -7.31% |
| 2005 | $43.26 M | 3.83% |
| 2004 | $41.67 M | -8.78% |
| 2003 | $45.68 M | -21.21% |
| 2002 | $57.98 M | 2.32% |
| 2001 | $56.66 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $9.25 B | 72,147.38% | 🇺🇸 USA |
 LabCorp LH | $12.90 B | 100,647.31% | 🇺🇸 USA |
 RadNet RDNT | $1.61 B | 12,524.00% | 🇺🇸 USA |
 Psychemedics PMD | $22.09 M | 72.56% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.59 B | 4,520.05% | 🇺🇸 USA |
 Qiagen QGEN | $1.96 B | 15,246.80% | 🇳🇱 Netherlands |